Related Experiment Videos
Experimental 6 log10 white cell-reduction filters for red cells
B J Sadoff1, R R Stromberg, K Miller
1Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross, Rockville, Maryland.
Transfusion
|February 1, 1992
Summary
New filters significantly reduce white blood cells (WBCs) in red blood cells (RBCs), enhancing transfusion safety. These advanced filters offer a 6 log10 WBC reduction, minimizing transfusion complications and preserving RBC quality.
Area of Science:
- Transfusion Medicine
- Blood Component Processing
- Filtration Technology
Background:
- White cell (WBC) reduction in blood components is crucial for minimizing transfusion-related complications.
- Existing filters achieve approximately 3 log10 WBC reduction, which is insufficient for certain safety goals.
- Complications include WBC-associated HLA alloimmunization and transmission of cell-associated viral diseases.
Purpose of the Study:
- To evaluate the performance of two experimental filters designed for enhanced WBC reduction.
- To assess the filters' ability to remove 6 log10 WBCs from fresh red blood cells (RBCs).
- To determine the impact of filtration on RBC storage parameters and shelf life.
Main Methods:
- Two experimental filters targeting 6 log10 WBC reduction were tested on fresh RBCs.
- Filtration time and RBC loss were measured under non-optimized conditions.
- Storage parameters of filtered RBCs were monitored over a 42-day period.
Main Results:
- Both experimental filters successfully achieved the objective of 6 log10 WBC reduction.
- Filtration was completed in under 40 minutes with less than 15% RBC loss.
- Filtered RBCs maintained normal storage parameters throughout the 42-day storage period.
Conclusions:
- The experimental filters demonstrate high efficacy in WBC reduction from RBCs.
- These filters, when integrated with sterile docking devices or collection sets, can provide highly WBC-reduced RBCs.
- This technology promises to improve transfusion safety by significantly reducing WBC-associated risks.